-
HSP90-Dependent Nanoparticles for FMD Immunity
2026-08-18
Lv et al. developed HACC-TNF-α-FMDV virus-like particle nanoparticles that couple antigen delivery with immunomodulation to improve dendritic-cell cross-presentation. The formulation enhanced HSP90-associated antigen processing, CD8+ T-cell activation, mucosal IgA, and systemic antibody responses in mouse models, offering a framework for vaccines that require both cellular and mucosal immunity.
-
Mitomycin C Workflows for Cancer Research
2026-08-18
Build reproducible Mitomycin C experiments around DNA replication inhibition, apoptosis signaling, and TRAIL sensitization rather than relying on a single viability endpoint. This guide also explains how the tRF16–ALKBH5 osteoarthritis study can inform assay architecture without overstating a cross-disease application.
-
AMPK–JAK2/STAT3 Axis in Obesity-Related Asthma
2026-08-17
A study in Inflammation identifies reduced AMPK activity and M1 macrophage polarization as linked features of obesity-related asthma. Using mouse and LPS-stimulated RAW264.7 macrophage models, the authors show that AMPK activation attenuates airway inflammation in association with modulation of the JAK2/STAT3 pathway, providing a mechanistic framework for metabolic-inflammatory research.
-
Haloprogin: Applied Antifungal Workflows
2026-08-17
Haloprogin supports reproducible screening across dermatophytes, Candida, and selected Gram-positive bacteria, while its formulation history makes it useful for topical infection-model design. This guide connects MIC/MFC testing with practical stock preparation, topical delivery, comparator selection, and troubleshooting.
-
TCEP Hydrochloride and the Next LFA Sensitivity Leap
2026-08-15
A translational perspective on how redox-controlled protein preparation, disulfide reduction, and capture-and-release assay architecture can be evaluated together to improve reproducibility and sensitivity in lateral flow development.
-
Deferoxamine mesylate for Ferroptosis Workflows
2026-08-14
Deferoxamine mesylate gives researchers a controllable way to separate iron-dependent oxidative injury from late-stage plasma-membrane failure. This workflow-oriented guide applies the compound to ferroptosis, HIF-1α stabilization, wound healing promotion, cancer models, and oxidative stress protection while emphasizing controls and interpretation.
-
(S)-(+)-Dimethindene maleate Protocol Guide
2026-08-14
This guide explains how to use (S)-(+)-Dimethindene maleate as a research reagent for M2 muscarinic and histamine H1 receptor antagonism when directly matched paper evidence is unavailable. It supports controlled in vitro and ex vivo workflows, but it should not be used to infer potency, clinical effects, diagnostic utility, or therapeutic performance.
-
Fosinopril sodium in ACE Inhibition Research
2026-08-13
Fosinopril sodium supports mechanism-focused ACE inhibition studies, cardiovascular disease models, and renal hemodynamics workflows without relying on DMSO-based stock preparation. This guide connects prodrug disposition, assay design, formulation control, and troubleshooting to improve reproducibility in hypertension research.
-
(S)-(+)-Methoprene Workflows for JH Studies
2026-08-13
Use (S)-(+)-Methoprene as a controllable juvenile hormone analog to separate receptor-driven developmental effects from endogenous hormone biosynthesis. This guide connects Met activation, insect metamorphosis inhibition, and miRNA–mRNA regulation with practical dosing, assay design, and troubleshooting strategies.
-
LDN-193189: Dissecting BMP-Driven Cell Plasticity
2026-08-12
LDN-193189 is an ALK inhibitor that enables branch-selective interrogation of BMP signaling in epithelial plasticity and barrier models. This article explains how to distinguish BMP-dependent effects from TGF-β-driven state changes using mechanistically aligned assays.
-
Veratridine: From Sodium Channels to Translation
2026-08-12
A mechanistic and translational perspective on Veratridine as a voltage-gated sodium channel opener, spanning excitotoxicity studies, blocker screening, assay design, and carefully bounded oncology applications.
-
HRP Goat Anti-Mouse IgG (H+L) for p21-LNP
2026-08-11
Explore how Affinity-Purified Goat Anti-Mouse IgG (H+L) supports rigorous p21-LNP bladder cancer studies. This assay-centered guide connects HRP detection chemistry with endpoint selection, controls, and translational interpretation.
-
N-Formimidoyl Thienamycin vs Cefoperazone
2026-08-11
This 1982 comparative study tested N-formimidoyl thienamycin (MK0787) against a broad panel of resistant clinical isolates and benchmarked it against several contemporary β-lactams. Its main contribution was to connect broad-spectrum MIC activity with bactericidal behavior and apparent independence from β-lactamase production, while also defining organism-specific differences relative to cefoperazone and cefotaxime.
-
PDHA1 Succinylation and Immune Escape in Cholangiocarcinoma
2026-08-10
The reference study identifies PDHA1 lysine 83 succinylation as a metabolic–immune switch in cholangiocarcinoma. By linking altered pyruvate dehydrogenase activity to alpha-ketoglutaric acid accumulation, OXGR1–MAPK signaling, and impaired macrophage MHC-II presentation, it provides a mechanistic rationale for combining succinylation inhibition with gemcitabine and cisplatin.
-
Safe DNA Gel Stain for Molecular Biology
2026-08-09
Safe DNA Gel Stain supports sensitive DNA and RNA gel visualization while enabling blue-light imaging and reducing reliance on ethidium bromide and UV exposure. This workflow-focused guide shows how to apply it to PCR quality control, cloning, RNA analysis, and studies such as MroGCL regulation in giant prawn spermatogenesis.